A measles virus encoding a CD19/CD3 bispecific T cell engager shows enhanced preclinical anti-BCP-ALL efficacy without significant toxicity.

Mol Ther Oncol · 2026 · PMC12860616 · PMID 41631160

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Among TCF3-HLF-positive cell lines, HAL-01 showed a trend toward enhanced cell killing compared to MV-Edm, whereas YCUB2 was resistant.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.